131 related articles for article (PubMed ID: 15573230)
1. Dysregulation of growth hormone in acquired generalized lipodystrophy.
Sahhar NN; Ahmad AT; Ammari FL; Ajlouni KM
Saudi Med J; 2004 Nov; 25(11):1766-7. PubMed ID: 15573230
[No Abstract] [Full Text] [Related]
2. Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy.
Park JY; Chong AY; Cochran EK; Kleiner DE; Haller MJ; Schatz DA; Gorden P
J Clin Endocrinol Metab; 2008 Jan; 93(1):26-31. PubMed ID: 17940115
[TBL] [Abstract][Full Text] [Related]
3. [Insulin therapy of type 2 diabetes: from simple to flexible--three strategies are available].
Liebl A
MMW Fortschr Med; 2012 Nov; 154 Spec No 3():66-71; quiz 72-3. PubMed ID: 23724722
[No Abstract] [Full Text] [Related]
4. Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin.
Blonde L; Sandberg MI; Guthrie RD
Diabetes Care; 1999 Jun; 22(6):1004-6. PubMed ID: 10372262
[No Abstract] [Full Text] [Related]
5. Metformin useful in combination with exogenous insulin.
Hanuschak LN
Diabetes Care; 1996 Jun; 19(6):671-2. PubMed ID: 8725873
[No Abstract] [Full Text] [Related]
6. [Researchers illuminate diabetes therapy].
Pflege Z; 2014 Feb; 67(2):126. PubMed ID: 24730335
[No Abstract] [Full Text] [Related]
7. [Sequential treatment with insulin glargine and metformin, and exenatide in a patient with newly diagnosed type-2 diabetes].
Kress S
Dtsch Med Wochenschr; 2010 May; 135(18):907-10. PubMed ID: 20425675
[TBL] [Abstract][Full Text] [Related]
8. Diabetes: insulin plus metformin for T2DM--are there benefits?
Bailey CJ
Nat Rev Endocrinol; 2012 Jun; 8(8):449-50. PubMed ID: 22733270
[No Abstract] [Full Text] [Related]
9. Effects of Metreleptin in Pediatric Patients With Lipodystrophy.
Brown RJ; Meehan CA; Cochran E; Rother KI; Kleiner DE; Walter M; Gorden P
J Clin Endocrinol Metab; 2017 May; 102(5):1511-1519. PubMed ID: 28324110
[TBL] [Abstract][Full Text] [Related]
10. HbA(1c) targets for type 2 diabetes: how many, …how far!
Giugliano D; Ceriello A; Esposito K
Diabetes Res Clin Pract; 2012 Jun; 96(3):414-5. PubMed ID: 21963106
[No Abstract] [Full Text] [Related]
11. Metformin: an antihyperglycemic drug for non-insulin-dependent diabetes mellitus.
Kupecz D
Nurse Pract; 1995 Jul; 20(7):70-2. PubMed ID: 7675343
[No Abstract] [Full Text] [Related]
12. [Insulin therapy in patients with type 2 diabetes].
Siegmund T; Schumm-Draeger PM
MMW Fortschr Med; 2008 May; 150(18):32-5; quiz 36. PubMed ID: 18533606
[No Abstract] [Full Text] [Related]
13. Rosiglitazone in combination with glimepiride plus metformin in type 2 diabetic patients.
Kiayias JA; Vlachou ED; Theodosopoulou E; Lakka-Papadodima E
Diabetes Care; 2002 Jul; 25(7):1251-2. PubMed ID: 12087036
[No Abstract] [Full Text] [Related]
14. Combined therapy with insulin plus oral agents: is there any advantage? An argument in favor.
Riddle MC
Diabetes Care; 2008 Feb; 31 Suppl 2():S125-30. PubMed ID: 18227472
[No Abstract] [Full Text] [Related]
15. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes.
Malone JK; Bai S; Campaigne BN; Reviriego J; Augendre-Ferrante B
Diabet Med; 2005 Apr; 22(4):374-81. PubMed ID: 15787659
[TBL] [Abstract][Full Text] [Related]
16. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
17. Pivotal role of timely basal insulin replacement after metformin failure in sustaining long-term blood glucose control at a target in type 2 diabetes.
Bolli GB; Lucidi P; Porcellati F; Fanelli CG
Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S220-4. PubMed ID: 21525459
[No Abstract] [Full Text] [Related]
18. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with meformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea: response to Barnett et al.
Mikhail N; Cope D
Diabetes Care; 2006 Oct; 29(10):2332-3; author reply 2333. PubMed ID: 17003325
[No Abstract] [Full Text] [Related]
19. Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes.
Arioglu E; Duncan-Morin J; Sebring N; Rother KI; Gottlieb N; Lieberman J; Herion D; Kleiner DE; Reynolds J; Premkumar A; Sumner AE; Hoofnagle J; Reitman ML; Taylor SI
Ann Intern Med; 2000 Aug; 133(4):263-74. PubMed ID: 10929166
[TBL] [Abstract][Full Text] [Related]
20. [Insulin therapy in type 2 diabetes].
Hummel M
MMW Fortschr Med; 2011 Jun; 153(23):56-9, 61; quiz 62. PubMed ID: 21688497
[No Abstract] [Full Text] [Related]
[Next] [New Search]
